Cargando…
ANTIBLASTIC IMMUNITY
1. Antipneumococcus serum possesses the power of inhibiting for a certain period of time the multiplication of pneumococci. 2. It also has the capacity of inhibiting the proteolytic and glycolytc functions of pneumococci. 3. This power is acquired for the first time or appears in increased amounts i...
Autores principales: | Dochez, A. R., Avery, O. T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1916
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2125341/ https://www.ncbi.nlm.nih.gov/pubmed/19867971 |
Ejemplares similares
-
STUDIES ON ANTIBLASTIC IMMUNITY
por: Blake, Francis G.
Publicado: (1917) -
ANTIBLASTIC PHENOMENA IN ACTIVE ACQUIRED IMMUNITY AND IN NATURAL IMMUNITY TO PNEUMOCOCCUS
por: Barber, M. A.
Publicado: (1919) -
Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection
por: Deidda, Martino, et al.
Publicado: (2019) -
Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection
por: Fazzini, Luca, et al.
Publicado: (2022) -
Animal Models in Studies of Cardiotoxicity Side Effects from Antiblastic Drugs in Patients and Occupational Exposed Workers
por: Lamberti, Monica, et al.
Publicado: (2014)